Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
In conjunction with market measures on the underlying equity, trading of Samsung Biologics’ stock futures and options was temporarily suspended at 07:45 KST on May 22, 2025, and resumed at 09:30 KST on the same day following the lift of the suspension.
📊 [Key Disclosure Details & Financial Figures]
- Disclosure Title: Trading Suspension and Resumption of Stock Futures and Options
- Target Product: Samsung Biologics Co., Ltd. Stock Futures & Stock Options
- Trading Suspension Date & Time: May 22, 2025, at 07:45 KST
- Trading Resumption Date & Time: May 22, 2025, at 09:30 KST
- Reason for Suspension / Resumption: Trading suspension and lifting of suspension on underlying asset
- Governing Rule: Article 74 of the Enforcement Rules of the Derivatives Market Business Regulations
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Resumption of Derivatives Trading and Related Market Notices
This disclosure provides notice that trading in Samsung Biologics’ stock futures and options has resumed following a temporary suspension triggered by market measures on the underlying stock.
Checking official market measures regarding the underlying equity and tracking future derivative market notices is essential.
Relevant details can be verified in subsequent official disclosures and future market notices issued by the Korea Exchange (KRX).
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
